Redhill Biopharma
RDHL
23 hedge funds and large institutions have $19.5M invested in Redhill Biopharma in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 5 closing their positions.
21% more capital invested
Capital invested by funds: $16.2M → $19.5M (+$3.32M)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
4% less funds holding
Funds holding: 24 → 23 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$178K |
| 2 |
FM
Family Management
New York
|
+$107K |
| 3 |
JP Morgan Chase
New York
|
+$44.5K |
| 4 |
PVH
Psagot Value Holdings
Tel Aviv,
Israel
|
+$26.7K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$17.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BHB
Bank Hapoalim BM
Tel Aviv,
Israel
|
-$356K |
| 2 |
Renaissance Technologies
New York
|
-$216K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$181K |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$117K |
| 5 |
OC
Oppenheimer & Co
New York
|
-$97.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Renaissance Technologies
New York
| – | -$216K | -25 | Closed |
|
|
27
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$181K | -21 | Closed |
|
|
28
DZ Bank
Frankfurt Am Main,
Germany
| – | -$117K | -14 | Closed |
|
|
AIM
29
Acrospire Investment Management
Chicago,
Illinois
| – | -$12K | -1 | Closed |
|
30
Creative Planning
Overland Park,
Kansas
| – | -$9K | -1 | Closed |
|
RDHL Hedge Fund Activity: Q3 2017 in Review
23 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q3 2017, worth a combined $19.5M — up 21% from $16.2M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of RDHL and 4 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 5 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $178K. The largest seller was Bank Hapoalim BM, cutting an estimated $356K.
- 23 institutional investors held Redhill Biopharma (RDHL) as of Q3 2017, down from 24 in Q2 2017.
- Funds reported $19.5M of Redhill Biopharma stock for Q3 2017, up 21% quarter-over-quarter.
- 4 funds opened new Redhill Biopharma positions in Q3 2017 and 5 closed out, a net change of -1 holder.
- The largest Redhill Biopharma buyer in Q3 2017 was Millennium Management, an estimated $178K added.
- The largest Redhill Biopharma seller in Q3 2017 was Bank Hapoalim BM, an estimated $356K sold.
Based on aggregated 13F filings for Q3 2017.